The AARP today released a watchdog analysis (using Medicare claims data) depicting the general increase in the price of the most popular prescription medications relative to prevailing inflationary trends. And, surprise! The lobbying group notes an almost 10 percent increase in the price of branded preparations straight from the manufacturer for 2009. Apparently, all but 6 of the over 200 brands studied showed any increase over the rates of inflation for that period. Pharma is quick to dispute the group’s findings as they do not include more precise reporting of actual point of purchase data to the consumer, forgoing mentions of rebates and plan discounts. | PDF LINK of AARP’s report

Related Posts Within Doctor Pundit:

1. Study: Generic Cardiovascular Drugs As Effective As Branded Ones Two-thousand eight has been dubbed the “year of the generic”...
2. Senator Touts Alliance by Pharma and AARP as Key Effort in Healthcare Reform The nation’s largest drug lobby, PhRMA, desperate to be included...
3. White House on Side of Pharma in Lawsuit Concerning Drug Prices Are there pharmaceutical companies that are accused of overcharging public...
4. Budget Office Releases New Projection on Effect of Repeal of Reform Law What does the Congressional Budget Office think that repeal of...
5. Report: Branded Drug Use Sharply Down, Generics Way Up A healthcare informatics company issues a report today that I...